These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 16224183

  • 1. Release of exotoxin A, peptidoglycan and endotoxin after exposure of clinical Pseudomonas aeruginosa isolates to carbapenems in vitro.
    Horii T, Muramatsu H, Monji A, Miyagishima D.
    Chemotherapy; 2005 Oct; 51(6):324-31. PubMed ID: 16224183
    [Abstract] [Full Text] [Related]

  • 2. Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa.
    Horii T, Ichiyama S, Ohta M, Kobayashi M.
    J Med Microbiol; 1999 Mar; 48(3):309-315. PubMed ID: 10334599
    [Abstract] [Full Text] [Related]

  • 3. An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli.
    Horii T, Kobayashi M, Sato K, Ichiyama S, Ohta M.
    J Antimicrob Chemother; 1998 Apr; 41(4):435-42. PubMed ID: 9598774
    [Abstract] [Full Text] [Related]

  • 4. Carbapenem-induced endotoxin release in gram-negative bacterial sepsis rat models.
    Horii T, Kobayashi M, Nadai M, Ichiyama S, Ohta M.
    FEMS Immunol Med Microbiol; 1998 Aug; 21(4):297-302. PubMed ID: 9753002
    [Abstract] [Full Text] [Related]

  • 5. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.
    Santajit S, Seesuay W, Mahasongkram K, Sookrung N, Ampawong S, Reamtong O, Diraphat P, Chaicumpa W, Indrawattana N.
    Sci Rep; 2019 Oct 17; 9(1):14928. PubMed ID: 31624289
    [Abstract] [Full Text] [Related]

  • 6. Proteolysis of Pseudomonas exotoxin A within hepatic endosomes by cathepsins B and D produces fragments displaying in vitro ADP-ribosylating and apoptotic effects.
    El Hage T, Lorin S, Decottignies P, Djavaheri-Mergny M, Authier F.
    FEBS J; 2010 Sep 17; 277(18):3735-49. PubMed ID: 20718861
    [Abstract] [Full Text] [Related]

  • 7. Neutralization of Pseudomonas auruginosa Exotoxin A by human neutrophil peptide 1.
    Zou G, de Leeuw E.
    Biochem Biophys Res Commun; 2018 Jun 22; 501(2):454-457. PubMed ID: 29738776
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa.
    Hirabayashi A, Kato D, Tomita Y, Iguchi M, Yamada K, Kouyama Y, Morioka H, Tetsuka N, Yagi T.
    J Med Microbiol; 2017 Nov 22; 66(11):1562-1572. PubMed ID: 28984565
    [Abstract] [Full Text] [Related]

  • 9. Regulation of toxA by PtxR in Pseudomonas aeruginosa PA103.
    Carty NL, Rumbaugh KP, Hamood AN.
    Can J Microbiol; 2003 Jul 22; 49(7):450-64. PubMed ID: 14569286
    [Abstract] [Full Text] [Related]

  • 10. The Pseudomonas aeruginosa alternative sigma factor PvdS controls exotoxin A expression and is expressed in lung infections associated with cystic fibrosis.
    Hunt TA, Peng WT, Loubens I, Storey DG.
    Microbiology (Reading); 2002 Oct 22; 148(Pt 10):3183-3193. PubMed ID: 12368452
    [Abstract] [Full Text] [Related]

  • 11. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV, Raivio TL, Olson JC, Woods DE, Storey DG.
    Microbiology (Reading); 2000 Aug 22; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [Abstract] [Full Text] [Related]

  • 12. The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.
    Sarac MS, Cameron A, Lindberg I.
    Infect Immun; 2002 Dec 22; 70(12):7136-9. PubMed ID: 12438396
    [Abstract] [Full Text] [Related]

  • 13. Norepinephrine represses the expression of toxA and the siderophore genes in Pseudomonas aeruginosa.
    Li W, Lyte M, Freestone PP, Ajmal A, Colmer-Hamood JA, Hamood AN.
    FEMS Microbiol Lett; 2009 Oct 22; 299(1):100-9. PubMed ID: 19686346
    [Abstract] [Full Text] [Related]

  • 14. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
    Yates SP, Merrill AR.
    Biochem J; 2004 May 01; 379(Pt 3):563-72. PubMed ID: 14733615
    [Abstract] [Full Text] [Related]

  • 15. Proteolytic cleavage of Pseudomonas aeruginosa exotoxin A in the presence of lipid bilayers of different composition.
    Nordera P, Menestrina G.
    FEBS Lett; 1998 Jan 16; 421(3):268-72. PubMed ID: 9468320
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models.
    Tsuji M, Matsuda H, Miwa H, Miyazaki S.
    J Antimicrob Chemother; 2003 Feb 16; 51(2):353-9. PubMed ID: 12562702
    [Abstract] [Full Text] [Related]

  • 17. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY, Galloway DR.
    J Biol Chem; 1995 Jan 13; 270(2):679-84. PubMed ID: 7822295
    [Abstract] [Full Text] [Related]

  • 18. In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice.
    Hirakata Y, Furuya N, Tateda K, Kaku M, Yamaguchi K.
    Infect Immun; 1993 Jun 13; 61(6):2468-73. PubMed ID: 8500881
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia Reduces the Pathogenicity of Pseudomonas aeruginosa by Decreasing the Expression of Multiple Virulence Factors.
    Schaible B, Rodriguez J, Garcia A, von Kriegsheim A, McClean S, Hickey C, Keogh CE, Brown E, Schaffer K, Broquet A, Taylor CT.
    J Infect Dis; 2017 May 01; 215(9):1459-1467. PubMed ID: 28368464
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.
    Jiang M, Yao J, Feng G.
    PLoS One; 2014 May 01; 9(5):e96609. PubMed ID: 24788626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.